Latest / Stock Movers / Citi Gains, Adobe/Figma Slide, Travere Therapeutics Soars
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News.
- 0:08Speaker 2: The Stock Mover's Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 1: I'm Jim Steadewek along with Carol Masser. Let's take a
- 0:19Speaker 1: look at some stocks on the move today. We're joined
- 0:22Speaker 1: by Bloomberg News Equities reporter Avalon Parnell Avalon. What are
- 0:25Speaker 1: you watching?
- 0:26Speaker 3: You can go ahead and start off with City Group.
- 0:27Speaker 3: That's ticker. See it rose two point six percent into
- 0:30Speaker 3: the close to end at its highest level since two
- 0:33Speaker 3: thousand and eight, which we all know why. That's a
- 0:35Speaker 3: big deal considering they've been in the midst of a
- 0:37Speaker 3: pretty long turnaround, and that's after the banklogged it's best
- 0:41Speaker 3: returns in five years despite a pretty volatile first quarter.
- 0:44Speaker 3: I think we can all say in the markets, Ana
- 0:46Speaker 3: Lyts say that the print was welcome news for many investors,
- 0:49Speaker 3: and Piper Sandler writing that the results were better than
- 0:51Speaker 3: expected nearly across the board.
- 0:53Speaker 2: That is wild.
- 0:56Speaker 3: Yeah, I feel like, considering what's not happening the base
- 0:59Speaker 3: outside of it was very easy to kind of get
- 1:01Speaker 3: focused on the downside, but clearly a little bit of
- 1:04Speaker 3: upside in city.
- 1:05Speaker 4: I mean there was a point with that stock drop
- 1:07Speaker 4: down to nothing dollar a share?
- 1:10Speaker 1: Where when was that? Two thousand and.
- 1:12Speaker 4: Eight and where I'm looking at my chart two thousand
- 1:16Speaker 4: and nine eight?
- 1:18Speaker 1: Is that right it?
- 1:20Speaker 4: I think maybe it was intra day, but it was
- 1:24Speaker 4: like nothing, I keep saying a dollar share, So God,
- 1:26Speaker 4: wouldn't that be terrible? Like okay, I'm just looking at
- 1:30Speaker 4: the chart. But it's really remarkable how much that we've
- 1:33Speaker 4: seen it go. I mean, it really did nothing for
- 1:35Speaker 4: such a long yeah, long long time. Okay, Okay, that's
- 1:42Speaker 4: what happened avalon and we give her all the.
- 1:45Speaker 1: Time because she comes in at four fifty.
- 1:48Speaker 4: Well, you say things that actually make us like think
- 1:50Speaker 4: and want to look more. It's really good anyway, go ahead, all.
- 1:54Speaker 1: Right, So let's go to some tech players.
- 1:56Speaker 3: Yes, so we have Adobe that's took her ADB and Figma,
- 1:59Speaker 3: which is to or fig very easy to remember. Big
- 2:02Speaker 3: Mus slid about four percent and Adobe dipped to one
- 2:04Speaker 3: point eight percent into the close. That's after the Information
- 2:07Speaker 3: reported that Anthropic is preparing its next flagship model, Claude Opus.
- 2:11Speaker 3: I kind of like that name. It's also preparing some
- 2:14Speaker 3: AI tools for designing websites and presentations, and practically everyone
- 2:19Speaker 3: continues to be scared about what exactly does that mean
- 2:22Speaker 3: for stocks like Adobe and Pigma, which are pretty big
- 2:25Speaker 3: software players in this space. Bloomberg Intelligence writing that they
- 2:29Speaker 3: expect the headline risk related to AI disruption to be
- 2:32Speaker 3: amplified with the release of Anthropics new model, and that
- 2:35Speaker 3: it will especially impact Figma and Adobe.
- 2:38Speaker 1: Bigma's down more than fifty percent this year. Yes, do
- 2:41Speaker 1: you remember this was a stock that after its IPO. Yeah,
- 2:44Speaker 1: one hundred and twenty two dollars a share. This is
- 2:47Speaker 1: back in August of twenty twenty five. It's now down
- 2:52Speaker 1: eighty five percent since then.
- 2:54Speaker 3: Wow.
- 2:55Speaker 4: Yeah, that's a big that's a big drop.
- 2:57Speaker 1: That's huge. So this is Nowgma now has a marketing
- 3:01Speaker 1: tap about nine point six billion dollars. Okay, you got
- 3:05Speaker 1: me thinking about Figma.
- 3:06Speaker 2: See this is what you do.
- 3:07Speaker 1: I know it is.
- 3:08Speaker 4: It's really cool.
- 3:09Speaker 1: Actually, you make us think you do.
- 3:10Speaker 4: You make us like like we're looking at something that
- 3:13Speaker 4: we maybe weren't looking at before.
- 3:14Speaker 1: It's very cool and remind us of the trouble we
- 3:17Speaker 1: have sticking to a single task. That's also true. We
- 3:21Speaker 1: really Okay, one of the reasons we love talking to
- 3:25Speaker 1: you is because your connection to healthcare.
- 3:29Speaker 3: Absolutely, so we can end with Travie Therapeutics. That's ticker TVTX.
- 3:34Speaker 3: Maybe you haven't heard of this name, but it surged
- 3:35Speaker 3: thirty seven percent to hit its highest level since two
- 3:38Speaker 3: thousand and five, and that's after the biotech's treatment for
- 3:41Speaker 3: a rare kidney disease one FDA approval in the US.
- 3:45Speaker 3: TD Cohen writing that the approval is a hamewark event,
- 3:48Speaker 3: especially considering this is the first and only therapy for
- 3:50Speaker 3: this rare kidney disease. Current estimates are about forty thousand
- 3:55Speaker 3: people in the US are impacted by it, So definitely
- 3:57Speaker 3: good news for the patients and also for a stock.
- 4:00Speaker 4: Yeah, absolutely like a solution. Hey, I just want you
- 4:04Speaker 4: to know I did go back and just checked on city.
- 4:06Speaker 4: It wasn't like, you know, crazy, here we go. They
- 4:08Speaker 4: briefly trade a below a dollar, hitting ninety seven cents
- 4:13Speaker 4: intra day on March in March fifth, two thousand and nine.
- 4:16Speaker 4: I remember because I remember thinking, you know, why did
- 4:19Speaker 4: you just throw like one thousand dollars or something that
- 4:22Speaker 4: you know we were so in it and you know
- 4:24Speaker 4: we have it would be up six, I mean.
- 4:27Speaker 1: Or more no, no, no, for what was it? It
- 4:29Speaker 1: was a dollar, it was below a.
- 4:30Speaker 4: Dollar for a moment. Wow, Like it's just like at
- 4:32Speaker 4: the depth of the financial crisis. So it's just you know,
- 4:35Speaker 4: you kind of think about it. But for a very
- 4:37Speaker 4: long time the stock didn't go anywhere if you look
- 4:40Speaker 4: at the chart. But interesting to see kind of where
- 4:43Speaker 4: it is today.
- 4:45Speaker 2: The Stock Mover's Report from Bloomberg Radio. Check back with
- 4:49Speaker 2: us throughout the day for the latest roundup of companies
- 4:52Speaker 2: making news on Wall Street and for the latest market
- 4:55Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 5:00Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 5:03Speaker 2: the Bloomberg Business app.